Valneva SE (VALN) Cash from Financing Activities (2021 - 2026)

Valneva SE (VALN) posted Cash from Financing Activities of -$5.5 million for Q1 2026, up 49.64% sequentially from -$10.9 million in Q4 2025, and up 6.51% YoY from -$5.2 million in Q1 2025.

Valneva SE (VALN) Cash from Financing Activities (2021 - 2026) Analysis & Trends

Valneva SE has reported Cash from Financing Activities for 6 years, with the latest figure at -$5.5 million in Q1 2026.

  • Quarterly Cash from Financing Activities rose 6.51% year-over-year to -$5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$195032.3 (down 100.54% YoY) and the FY2025 annual result came in at -$722871.0, down 102.18% from the prior year.
  • Cash from Financing Activities grew to -$5.5 million in Q1 2026 per VALN's latest filing, from -$10.9 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $10.3 billion in Q3 2023 and troughed at -$10.3 billion in Q2 2023.
  • A 5-year average of $18.7 million and a median of -$649994.6 in 2025 frame the typical range for Cash from Financing Activities.
  • The widest YoY moves for Cash from Financing Activities: up 61612.28% in 2023, down 9392.38% in 2023.
  • Over 5 years, Cash from Financing Activities stood at $95.4 million in 2022, then sank by 58.32% to $39.7 million in 2023, then sank by 112.34% to -$4.9 million in 2024, then tumbled by 122.23% to -$10.9 million in 2025, then soared by 49.64% to -$5.5 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered -$5.5 million, -$10.9 million, and -$649994.6 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 2.42 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -6.05 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -207,909.22
7 Royalty Pharma 33.72 Bn 35.84 Bn - -273.15 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 36.24 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 27.18 Mn
10 Valneva SE 618.67 Mn 477.41 Mn 1.86 Mn 33.92 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 33.92 Mn
Jun 30, 2026 33.92 Mn
Mar 31, 2026 -5.49 Mn
Mar 31, 2026 -5.49 Mn
Dec 31, 2025 -10.90 Mn
Dec 31, 2025 -10.90 Mn
Sep 30, 2025 -649,994.63
Sep 30, 2025 -649,994.63
Jun 30, 2025 16.84 Mn
Jun 30, 2025 16.84 Mn
Mar 31, 2025 -5.87 Mn
Mar 31, 2025 -5.87 Mn
Dec 31, 2024 -4.90 Mn
Dec 31, 2024 -4.90 Mn
Sep 30, 2024 56.95 Mn
Sep 30, 2024 56.95 Mn
Jun 30, 2024 -9.83 Mn
Jun 30, 2024 -9.83 Mn
Mar 31, 2024 -8.10 Mn
Mar 31, 2024 -8.10 Mn